5.5.2014
•
News
Publications
Jan Dědič’s Interview for Hospodářské noviny
Professor Jan Dědič, a KŠB partner and expert lawyer involved in the re-enactment of Czech private law, explains how he feels about a number issues introduced by the new Corporations Act.

The interview focuses on various classes of shares attaching various voting rights or various dividend rights. Professor Dědič welcomes the wider diversity since he believes that “investors will bear greater responsibility as a result.” He also says that “the new classes of shares will be taken advantage of in cases where new companies are established, new shares issued or where a strategic investor enters a company.”
The shares discussed in the interview included shares with a greater amount of voting rights, fixed-profit shares and shares with a so-called subordinate share in the market. The entire interview (in Czech) is available here.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.